Open original FDA record ↗Recall record
- FDA identifier
- Z-2966-2020
- Company in FDA record
- RANDOX LABORATORIES, LTD.
- FDA record creation date
- Sep 14, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Randox Ammonia reagents are being recalled from the field due to a positive bias of up to 140mol/l being observed on patient samples.
Source facts
- Action
- The firm, Randox Laboratories Ltd., sent an "Urgent Medical Device Correction" letter dated 30th July 2020 to it customers. The letter described the product, problem and actions to be taken. The customers were instructed to do the following: - Discontinue use of, quarantine and discard any stock of AM1015, batch 517541 and AM1054, batch 512103 immediately. - Review results generated with the affected batches in line with the clinical profile of the patient. - Discuss the contents of this notice with your Medical Director. -Review your reagent inventory of these products and assess your laboratory needs for reimbursement for discarded inventory. -Complete and return the response form 12187-QA to technical.services@randox.com within five working days. If you have any questions or concerns please contact Randox Technical Services. Local at Tel: +1 304 728 2890 Toll Free 866 4 RANDOX Email: customersupportusa@randox.com and PR at Tel: 1-787-701-7000 Email: Jose.Rosario@randox.com.
- Initiated
- 2020-07-30
- Root cause
- Under Investigation by firm
- Terminated
- 2021-02-03
- Distribution
- US Distribution to states of: VA, UT, WV and country of : Canada
- Recall number
- Z-2966-2020
- Recall status
- Terminated
- CDRH record ID
- 183154
- FDA record created
- 2020-09-14
- Recall event number
- 86238